Invention Grant
- Patent Title: Advantageous benzofuran compositions for mental disorders or enhancement
-
Application No.: US18077966Application Date: 2022-12-08
-
Publication No.: US11767305B2Publication Date: 2023-09-26
- Inventor: Matthew Baggott
- Applicant: Tactogen Inc
- Applicant Address: US CA Palo Alto
- Assignee: Tactogen Inc
- Current Assignee: Tactogen Inc
- Current Assignee Address: US CA Palo Alto
- Agency: Knowles Intellectual Property Strategies, LLC
- Main IPC: C07D307/81
- IPC: C07D307/81 ; A61P25/18 ; A61P25/24
Abstract:
Pharmaceutically active benzofuran compositions for the treatment of mental disorders or for mental enhancement, including for entactogenic therapy. The present invention also includes benzofuran compounds, compositions, and methods for generally modulating central nervous system activity and treating central nervous system disorders.
Public/Granted literature
- US20230150963A1 ADVANTAGEOUS BENZOFURAN COMPOSITIONS FOR MENTAL DISORDERS OR ENHANCEMENT Public/Granted day:2023-05-18
Information query
